Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
Submitted by
admin
on September 14, 2017 - 9:56am
Source:
Fierce Pharma
News Tags:
EASD
AstraZeneca
Farixga
diabetes
Headline:
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
Do Not Allow Advertisers to Use My Personal information
